Glassman Wealth Services’s Amedisys AMED Stock Holding History

Glassman Wealth Services’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23	Closed	-$2.19K	–	282
2023 Q4	$2.19K	Hold	23	–	–	﹤0.01%	1325
2023 Q3	$2.15K	Hold	23	–	–	﹤0.01%	1308
2023 Q2	$2.1K	Hold	23	–	–	﹤0.01%	1227
2023 Q1	$1.69K	Buy	+23	New	+$1.99K	﹤0.01%	1293
2022 Q3	–	Sell	-1	Closed	–	–	1636
2022 Q2	$0	Sell	1 -12	-92%	-$1.53K	﹤0.01%	1647
2022 Q1	$2K	Buy	13 +11	+550%	+$1.64K	﹤0.01%	1186
2021 Q4	$0	Sell	2 -6	-75%	-$964	﹤0.01%	1618
2021 Q3	$1K	Buy	+8	New	+$1.66K	﹤0.01%	1263
2021 Q1	–	Sell	-37	Closed	-$11K	–	1380
2020 Q4	$11K	Hold	37	–	–	﹤0.01%	689
2020 Q3	$9K	Buy	+37	New	+$8.41K	﹤0.01%	631
2019 Q4	–	Sell	-3	Closed	–	–	1156
2019 Q3	$0	Buy	+3	New	+$391	﹤0.01%	1031

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Glassman Wealth Services's AMED Position: Q1 2024 in Review

Glassman Wealth Services sold out of Amedisys (AMED) in Q1 2024, closing a stake of 23 shares — an estimated $2.19K sold.

Glassman Wealth Services first reported a position in AMED in Q3 2019 and held it in 11 quarters. The position peaked at $11K in Q4 2020. 283 funds tracked by Wall St. Rank hold AMED as of Q1 2024.

Glassman Wealth Services reported no remaining Amedisys position as of Q1 2024 after selling out during the quarter.
Glassman Wealth Services sold 23 Amedisys shares in Q1 2024, an estimated $2.19K.
Glassman Wealth Services first reported a position in Amedisys in Q3 2019 and held it in 11 quarters.
Glassman Wealth Services's Amedisys position peaked at $11K in Q4 2020.
283 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.